Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lusutrombopag vs placebo for thrombocytopenia in chronic liver disease patients undergoing elective invasive procedures (China phase 3)
CTR20192384Phase 3Completed
- Sponsor
- Eddingpharm
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lusutrombopag in Thrombocytopenia, chronic liver disease (CLD), sponsored by Eddingpharm. Started Apr 2020; status: completed.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on CTR20192384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192384.